Cryo-Cell International, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Cryo-Cell International, Inc. (CCEL) is 35.62M

According to Cryo-Cell International, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 35.62M. This represents a change of -6.10% compared to the average of 37.94M of the last 4 quarters.

Cryo-Cell International, Inc. (CCEL) Historical Enterprise Value (quarterly & annually)

How has CCEL Enterprise Value performed in the past?

The mean historical Enterprise Value of Cryo-Cell International, Inc. over the last ten years is 60.67M. The current 35.62M Enterprise Value has changed 5.77% with respect to the historical average. Over the past ten years (40 quarters), CCEL's Enterprise Value was at its highest in in the November 2021 quarter at 95.30M. The Enterprise Value was at its lowest in in the February 2026 quarter at 29.53M.

Cryo-Cell International, Inc. (CCEL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cryo-Cell International, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cryo-Cell International, Inc. (CCEL) Average Enterprise Value

How has CCEL Enterprise Value performed in the past?

The current Enterprise Value of Cryo-Cell International, Inc. (CCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cryo-Cell International, Inc. (CCEL) Enterprise Value vs. Peers

How is CCEL’s Enterprise Value compared to its peers?

Cryo-Cell International, Inc.’s Enterprise Value is less than Zynex, Inc. (60.05M), greater than Jasper Therapeutics, Inc. (-3633833.00), greater than NeuroOne Medical Technologies Corporation (11.76M), less than 111, Inc. (200.71M), less than P3 Health Partners Inc. (71.17M), greater than Mural Oncology plc (-19941249.00), less than Alterity Therapeutics Limited (66.24M), greater than Evaxion Biotech A/S (-500936.00), greater than Liminatus Pharma, Inc. Class A Common Stock (2.37M), greater than Rockwell Medical, Inc. (31.94M),

Build a custom stock screener for Cryo-Cell International, Inc. (CCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cryo-Cell International, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cryo-Cell International, Inc. (CCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cryo-Cell International, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.